Nicotine Replacement and Counseling In Adolescents
A Randomized Trial of the Nicotine Nasal Spray in Adolescent Smokers
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of this pilot study is to determine the feasibility and utility of using the nicotine nasal spray (NNS) in adolescent smokers who want to quit smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Sep 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 19, 2008
CompletedFirst Posted
Study publicly available on registry
February 28, 2008
CompletedFebruary 28, 2008
May 1, 2007
1.7 years
February 19, 2008
February 27, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Self-reported smoking abstinence verified by both expired-air carbon monoxide and salivary cotinine.
12 weeks
Secondary Outcomes (1)
Acceptability of the Nicotine Nasal Spray by Adolescents.
8 weeks
Study Arms (2)
1
EXPERIMENTAL8 weeks or counseling plus 6 weeks of nicotine nasal spray
2
ACTIVE COMPARATOR8 weeks or counseling only.
Interventions
8 weeks or counseling plus 6 weeks of nicotine nasal spray (2 sprays each nostril as needed).
Eligibility Criteria
You may qualify if:
- Be between 15 and 18 years-old
- Smoke 5 or more cigarettes per day (cpd) for at least 6 months and want to quit smoking.
You may not qualify if:
- Adolescents who were using or had used nicotine replacement in the prior week were excluded.
- Those who used bupropion (Zyban®) within the past 30 days were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSF
San Francisco, California, 94118, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Rubinstein, MD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 19, 2008
First Posted
February 28, 2008
Study Start
September 1, 2005
Primary Completion
May 1, 2007
Study Completion
July 1, 2007
Last Updated
February 28, 2008
Record last verified: 2007-05